ClinicalTrials.govpublic full text
Study of the Benefit of Early Treatment With an Endothelin Inhibitor (Bosentan) in Patients With Sudden Blindness Due to Giant Cell Arteritis: CECIBO
arteritis, giant cell, blindness and low vision, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 855846
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.